| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.495 | 4.892 | 6.054 | 16.309 | 23.735 | 19.014 | 17.325 | 18.163 | 14.768 | 12.934 |
| Total Income - EUR | 5.495 | 4.892 | 9.338 | 16.309 | 23.735 | 19.014 | 17.433 | 18.272 | 14.768 | 12.934 |
| Total Expenses - EUR | 2.652 | 4.173 | 2.816 | 5.186 | 6.595 | 6.006 | 5.784 | 3.920 | 2.910 | 3.319 |
| Gross Profit/Loss - EUR | 2.843 | 719 | 6.522 | 11.123 | 17.139 | 13.008 | 11.649 | 14.352 | 11.858 | 9.616 |
| Net Profit/Loss - EUR | 2.678 | 572 | 5.958 | 10.638 | 16.427 | 12.465 | 11.126 | 13.760 | 9.998 | 8.108 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neuroclinic Dr. Ghiţuleasa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.002 | 21.685 | 185 | 11.380 | 7.907 | 4.654 | 1.517 | 0 | 0 | 0 |
| Current Assets | 3.471 | 2.553 | 6.612 | 15.941 | 16.905 | 13.996 | 13.405 | 15.215 | 10.403 | 9.284 |
| Inventories | 204 | 260 | 198 | 194 | 254 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 484 | 124 | 986 | 967 | 117 | 0 | 10.377 | 8.218 | 5 |
| Cash | 3.268 | 1.808 | 6.289 | 14.761 | 15.685 | 13.879 | 13.405 | 4.838 | 2.185 | 9.279 |
| Shareholders Funds | 2.607 | 3.152 | 6.573 | 17.090 | 16.478 | 12.515 | 11.175 | 13.808 | 10.047 | 8.156 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.867 | 21.085 | 223 | 10.230 | 8.335 | 6.136 | 3.748 | 1.406 | 356 | 1.128 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroclinic Dr. Ghiţuleasa Srl